Evidence map›Paper›PMID 24899502›Full record

Trial reportJournal of immunology (Baltimore, Md. : 1950)2014

Coordinated histone H3 methylation and acetylation regulate physiologic and pathologic fas ligand gene expression in human CD4+ T cells.

Smita S Ghare, Swati Joshi-Barve, Akshata Moghe, Madhuvanti Patil, David F Barker, Leila Gobejishvili, Guy N Brock, Matthew Cave, Craig J McClain, Shirish S Barve

Open access · bronzeAbstract readClinical Trial
In one paragraph

Trial report in Journal of immunology (Baltimore, Md. : 1950), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 32 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Premature termination codons in theProceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Acrolein enhances epigenetic modifications, FasL expression and hepatocyte toxicity induced by anti-HIV drug Zidovudine.Toxicology in vitro : an international journal published in association with BIBRA · 2016
    Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Smita S GhareDepartment of Medicine, University of Louisville, Louisville, KY 40202; University of Louisville Alcohol Research Center, University of Louisville, Louisville, KY 40202;
Swati Joshi-BarveDepartment of Medicine, University of Louisville, Louisville, KY 40202; University of Louisville Alcohol Research Center, University of Louisville, Louisville, KY 40202; Department of Pharmacology and Toxicology, University of Louisville, Louisville, KY 40202; and.
Akshata MogheUniversity of Louisville Alcohol Research Center, University of Louisville, Louisville, KY 40202; Department of Pharmacology and Toxicology, University of Louisville, Louisville, KY 40202; and.
Madhuvanti PatilUniversity of Louisville Alcohol Research Center, University of Louisville, Louisville, KY 40202; Department of Pharmacology and Toxicology, University of Louisville, Louisville, KY 40202; and.
David F BarkerDepartment of Medicine, University of Louisville, Louisville, KY 40202; University of Louisville Alcohol Research Center, University of Louisville, Louisville, KY 40202;
Leila GobejishviliDepartment of Medicine, University of Louisville, Louisville, KY 40202; University of Louisville Alcohol Research Center, University of Louisville, Louisville, KY 40202;
Guy N BrockDepartment of Bioinformatics and Biostatistics, University of Louisville, Louisville, KY 40202.
Matthew CaveDepartment of Medicine, University of Louisville, Louisville, KY 40202; University of Louisville Alcohol Research Center, University of Louisville, Louisville, KY 40202; Department of Pharmacology and Toxicology, University of Louisville, Louisville, KY 40202; and.
Craig J McClainDepartment of Medicine, University of Louisville, Louisville, KY 40202; University of Louisville Alcohol Research Center, University of Louisville, Louisville, KY 40202; Department of Pharmacology and Toxicology, University of Louisville, Louisville, KY 40202; and.
Shirish S BarveDepartment of Medicine, University of Louisville, Louisville, KY 40202; University of Louisville Alcohol Research Center, University of Louisville, Louisville, KY 40202; Department of Pharmacology and Toxicology, University of Louisville, Louisville, KY 40202; and shirishbarve@gmail.com.
University of Louisville · US

Funding

Translational Research/Education ComponentP60AA009803 · NIAAA · LSU HEALTH SCIENCES CENTER · PI DAVID A WELSH · 2004 to 2026
$42.6M
PILOT--IMPACT OF ALCOHOLISM ON AIDS ASOCIATED MUSCLE WASTINGP50AA009803 · NIAAA · LOUISIANA STATE UNIV HSC NEW ORLEANS · PI NELSON, STEVE · 1994 to 2003
$7.2M
UOFL ENVIRONMENTAL HEALTH SCIENCES TRAINING PROGRAMT32ES011564 · NIEHS · UNIVERSITY OF LOUISVILLE · PI David W Hein, John Pierce Wise · 2004 to 2026
$7.1M
Tumor Necrosis Factor and Alcoholic Liver DiseaseR37AA010762 · NIAAA · UNIVERSITY OF LOUISVILLE · PI MCCLAIN, CRAIG J. · 2001 to 2010
$3.6M
S-adenosylhomocysteine and S-adenosylmethionine in Alcoholic Liver DiseaseR01AA015970 · NIAAA · UNIVERSITY OF LOUISVILLE · PI MCCLAIN, CRAIG J. · 2005 to 2010
$2.0M
Cyclic AMP, Cytokine Modulation and Alcoholic Liver DiseaseR01AA018869 · NIAAA · UNIVERSITY OF LOUISVILLE · PI MCCLAIN, CRAIG J. · 2009 to 2013
$1.7M
Biomarkers for SteatohepatitisRC2AA019385 · NIAAA · UNIVERSITY OF LOUISVILLE · PI MCCLAIN, CRAIG J. · 2009 to 2010
$1.6M
Mechanisms for alcohol induced gut barrier dysfunction in ALDR01AA023681 · NIAAA · UNIVERSITY OF LOUISVILLE · PI MCCLAIN, CRAIG J. · 2014 to 2018
$1.6M
Mechanisms of Alcohol-Induced ImmunosuppressionR01AA014371 · NIAAA · UNIVERSITY OF LOUISVILLE · PI BARVE, SHIRISH S · 2004 to 2010
$1.6M
Novel therapies in alcoholic hepatitis University of LouisvilleU01AA021901 · NIAAA · UNIVERSITY OF LOUISVILLE · PI MCCLAIN, CRAIG J. · 2012 to 2017
$1.5M
Alcohol Liver Disease and Alcohol-Nutrient InteractionsP01AA017103 · NIAAA · UNIVERSITY OF LOUISVILLE · PI MCCLAIN, CRAIG J. · 2008 to 2010
$1.3M
Zinc supplementation in alcoholic cirrhosisK23AA018399 · NIAAA · UNIVERSITY OF LOUISVILLE · PI CAVE, MATTHEW C · 2010 to 2014
$1.0M
BLRD VA I01 BX000350NIAAA NIH HHS K23 AA018399NIAAA NIH HHS P01 AA017103NIAAA NIH HHS P01AA017103NIAAA NIH HHS P50 AA009803NIAAA NIH HHS P60 AA009803NIAAA NIH HHS P60AA009803NIAAA NIH HHS R01 AA014371NIAAA NIH HHS R01 AA015970NIAAA NIH HHS R01AA015970NIAAA NIH HHS R01 AA018869NIAAA NIH HHS R01AA018869NIAAA NIH HHS R01 AA023681NIAAA NIH HHS R37 AA010762NIAAA NIH HHS R37AA010762NIAAA NIH HHS RC2 AA019385NIAAA NIH HHS RC2AA019385NIAAA NIH HHS U01 AA021901NIEHS NIH HHS L30 ES015952NIEHS NIH HHS T32 ES011564NIEHS NIH HHS T35 ES014559NIEHS NIH HHS T35ES014559
6 · The paper itself

Abstract

Activation-induced Fas ligand (FasL) mRNA expression in CD4+ T cells is mainly controlled at transcriptional initiation. To elucidate the epigenetic mechanisms regulating physiologic and pathologic FasL transcription, TCR stimulation-responsive promoter histone modifications in normal and alcohol-exposed primary human CD4+ T cells were examined. TCR stimulation of normal and alcohol-exposed cells led to discernible changes in promoter histone H3 lysine trimethylation, as documented by an increase in the levels of transcriptionally permissive histone 3 lysine 4 trimethylation and a concomitant decrease in the repressive histone 3 lysine 9 trimethylation. Moreover, acetylation of histone 3 lysine 9 (H3K9), a critical feature of the active promoter state that is opposed by histone 3 lysine 9 trimethylation, was significantly increased and was essentially mediated by the p300-histone acetyltransferase. Notably, the degree of these coordinated histone modifications and subsequent recruitment of transcription factors and RNA polymerase II were significantly enhanced in alcohol-exposed CD4+ T cells and were commensurate with the pathologic increase in the levels of FasL mRNA. The clinical relevance of these findings is further supported by CD4+ T cells obtained from individuals with a history of heavy alcohol consumption, which demonstrate significantly greater p300-dependent H3K9 acetylation and FasL expression. Overall, these data show that, in human CD4+ T cells, TCR stimulation induces a distinct promoter histone profile involving a coordinated cross-talk between histone 3 lysine 4 and H3K9 methylation and acetylation that dictates the transcriptional activation of FasL under physiologic, as well as pathologic, conditions of alcohol exposure.

Indexed as

Alcohol DrinkingCD4-Positive T-LymphocytesFas Ligand ProteinFemaleGene Expression RegulationHistonesHumansMaleMethylationp300-CBP-Associated Factorp300-CBP Transcription FactorsReceptors, Antigen, T-CellFASLG protein, humanFas Ligand ProteinHistonesp300-CBP-Associated Factorp300-CBP Transcription FactorsReceptors, Antigen, T-Cell

Identifiers

PMID24899502
PMCPMC5096587
OpenAlexW1891643029

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.